GeneDx Holdings (WGS) EBIT (QoQ) (2020 - 2026)
Powered by 
Analysis
GeneDx Holdings (WGS) EBIT (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.63% |
| Mar 31, 2026 | -303.73% |
| Dec 31, 2025 | -337.87% |
| Sep 30, 2025 | -136.28% |
| Jun 30, 2025 | 296.88% |
| Mar 31, 2025 | -151.68% |
| Dec 31, 2024 | 213.19% |
| Sep 30, 2024 | 26.46% |
| Jun 30, 2024 | 22.55% |
| Mar 31, 2024 | 46.73% |
| Dec 31, 2023 | 40.32% |
| Sep 30, 2023 | 16.77% |
| Jun 30, 2023 | 14.48% |
| Mar 31, 2023 | 81.42% |
| Dec 31, 2022 | -257.74% |
| Sep 30, 2022 | 44.16% |
| Jun 30, 2022 | -82.13% |
| Mar 31, 2022 | 22.87% |
| Dec 31, 2021 | -31.17% |
| Sep 30, 2021 | -94.21% |